MB Venture Partners — Full Portfolio
5 tracked investments · listed companies and verified rows first
Hapten Sciences develops early-stage pharmaceutical products focused on dermatological health, with its lead candidate PDC-APB in clinical development as a preventive immunotherapy for contact dermatitis caused by exposure to poisonous plants.
BiotechHealthtechMedical DevicesMemphis, US
Raymond J Hage(Executive Officer, Director, Promoter)
BoardGary Prosterman(Executive Officer, Director, Promoter)Stephen I. Bandak(Director)
Board seatGary Stevenson· per SEC Form D · $1.2M raise · filed Feb 2017
HealthtechAustin, US
Paul Gunnoe(Executive Officer, Director)Adam Deitz(Executive Officer, Director)
BoardJohn Rodakis(Director)Gerald L. DeVries, Jr.(Director)Gary Stevenson(Director)Nelson Jaeggli(Director)
Co-investorsTEXO Ventures
SOMAVAC makes a smart surgical drain pump that delivers continuous sensor-controlled negative pressure therapy to the deep wound space, replacing traditional JP bulb drains and enabling earlier drain removal after surgery.
HardwareHealthtechMedical DevicesMemphis, US
Elizabeth Hoff(CEO)in
Co-investorsInnova Memphis, Inc.Launch Tennessee
SweetBio develops wound care dressings that combine collagen and Mānuka honey to help close chronic and acute non-healing wounds.
BiotechHealthtechMedical DevicesMemphis, US
Isaac Rodriguez(Executive Officer, Director)inKayla Rodriguez(Executive Officer, Director)inMarsalas Whitaker(Executive Officer, Director)inKevin Graff(Executive Officer)
Co-investorsInnova Memphis, Inc.Launch TennesseeVamosVenturesInnova
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






